Radioprotective effects of hesperidin on oxidative damages and histopathological changes induced by X-irradiation in rats heart tissue

Journal of Medical Physics

Volumn 41, Issue 3, 2016, Pages 182-191

  Rezaeyan, Abolhasan ^a   Haddadi, Gholam Hassan ^b   Hosseinzadeh, Massood ^c   Moradi, Maryam ^a   Najafi, Masoud ^d  

^a FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiomyopathy; cardiotoxicity; hesperidin; radioprotector

Indexed keywords

FLAVONOID; HESPERIDIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART; HEART MUSCLE FIBROSIS; HEART PROTECTION; HISTOPATHOLOGY; LIPID PEROXIDATION; MACROPHAGE; MALE; MAST CELL; MYOCARDITIS; NONHUMAN; OXIDATIVE STRESS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RADIATION SICKNESS; RAT; X IRRADIATION;

EID: 84986252270     PISSN: 09716203     EISSN: 19983913     Source Type: Journal    
DOI: 10.4103/0971-6203.189482     Document Type: Article

References (49)

1. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003;45:55-75.
2. Madan R, Benson R, Sharma DN, Julka PK, Rath GK. Radiation induced heart disease: Pathogenesis, management and review literature. J Egypt Natl Canc Inst 2015;27:187-93.
3. Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 2007;25:43-9.
4. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects. J Clin Oncol 2007;25:3991-4008.
5. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat Res 1999;152:374-89.
6. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010;340:b5349.
7. Marmot MG, Syme SL, Kagan A, Kato H, Cohen JB, Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol 1975;102:514-25.
8. Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: A clinical update. Cardiol Res Pract 2011;2011:317659.
9. Boerma M, Hauer-Jensen M. Preclinical research into basic mechanisms of radiation-induced heart disease. Cardiol Res Pract 2010;2011. pii: 858262.
10. Lett JT. Damage to cellular DNA from particulate radiations, the efficacy of its processing and the radiosensitivity of mammalian cells. Emphasis on DNA double strand breaks and chromatin breaks. Radiat Environ Biophys 1992;31:257-77.
11. Dainiak N, Tan BJ. Utility of biological membranes as indicators for radiation exposure: Alterations in membrane structure and function over time. Stem Cells 1995;13 Suppl 1:142-52.
12. Kaya H, Delibas N, Serteser M, Ulukaya E, Ozkaya O. The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther Onkol 1999;175:285-8.
13. Taysi S, Uslu C, Akcay F, Sutbeyaz MY. Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg Today 2003;33:651-4.
14. Halliwell B. Oxidative stress and neurodegeneration: Where are we now? J Neurochem 2006;97:1634-58.
15. Ertekin MV, Koçer I, Karslioglu I, Taysi S, Gepdiremen A, Sezen O, et al. Effects of oral Ginkgo biloba supplementation on cataract formation and oxidative stress occurring in lenses of rats exposed to total cranium radiotherapy. Jpn J Ophthalmol 2004;48:499-502.
16. Noaman E, Zahran AM, Kamal AM, Omran MF. Vitamin E and selenium administration as a modulator of antioxidant defense system: Biochemical assessment and modification. Biol Trace Elem Res 2002;86:55-64.
17. rd. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003;17:24-38.
18. Sun J, Chen Y, Li M, Ge Z. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med 1998;24:586-93.
19. Polat MF, Taysi S, Gul M, Cikman O, Yilmaz I, Bakan E, et al. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct 2002;20:327-31.
20. Wilmsen PK, Spada DS, Salvador M. Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 2005;53:4757-61.
21. Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytother Res 2015;29:323-31.
22. Kuntic V, Brboric J, Holclajtner-Antunovic I, Uskokovic-Markovic S. Evaluating the bioactive effects of flavonoid hesperidin - A new literature data survey. Vojnosanit Pregl 2014;71:60-5.
23. Lauk S, Kiszel Z, Buschmann J, Trott KR. Radiation-induced heart disease in rats. Int J Radiat Oncol Biol Phys 1985;11:801-8.
24. Gürses I, Özeren M, Serin M, Yücel N, Erkal HS. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract 2014;210:863-71.
25. Hosseinimehr SJ, Nemati A. Radioprotective effects of hesperidin against gamma irradiation in mouse bone marrow cells. Br J Radiol 2006;79:415-8.
26. Pradeep K, Park SH, Ko KC. Hesperidin a flavanoglycone protects against gamma-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. Eur J Pharmacol 2008;587:273-80.
27. Armstrong D, Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994;366:43-58.
28. th ed. Philadelphia: Churchill Livingstone/Elsevier; 2008. p. 121-34.
29. nd ed. Ohio: Battelle Press; 1980. p. 189-90.
30. th ed. Philadelphia: Churchill Livingstone/Elsevier; 2008. p. 135-60.
31. nd ed. Philadelphia, London: Lippincott Williams and Wilkins; 2010. p. 28.
32. nd ed. Philadelphia: W.B. Saunders; 2010. p. 761.
33. Li C, Zhou HM. The role of manganese superoxide dismutase in inflammation defense. Enzyme Res 2011;2011:387176.
34. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: Semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003;201:28-36.
35. Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett 2012;327:48-60.
36. Zhao W, Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: Therapeutic implications. Curr Med Chem 2009;16:130-43.
37. Stewart FA, Heeneman S, Te Poele J, Kruse J, Russell NS, Gijbels M, et al. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 2006;168:649-58.
38. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007;217:65-78.
39. Levick SP, Meléndez GC, Plante E, McLarty JL, Brower GL, Janicki JS. Cardiac mast cells: The centrepiece in adverse myocardial remodelling. Cardiovasc Res 2011;89:12-9.
40. Palaniyandi Selvaraj S, Watanabe K, Ma M, Tachikawa H, Kodama M, Aizawa Y. Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy. Biol Pharm Bull 2005;28:2128-32.
41. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: A new therapeutic target? Circulation 2004;109:1580-9.
42. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management. Circulation 2004;109:3122-31.
43. Weintraub NL, Jones WK, Manka D. Understanding radiation-induced vascular disease. J Am Coll Cardiol 2010;55:1237-9.
44. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993;270:1949-55.
45. Carlson RG, Mayfield WR, Normann S, Alexander JA. Radiation-associated valvular disease. Chest 1991;99:538-45.
46. Shapiro CL, Hardenbergh PH, Gelman R, Blanks D, Hauptman P, Recht A, et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 1998;16:3493-501.
47. Pradeep K, Ko KC, Choi MH, Kang JA, Chung YJ, Park SH. Protective effect of hesperidin, a citrus flavanoglycone, against gamma-radiation-induced tissue damage in Sprague-Dawley rats. J Med Food 2012;15:419-27.
48. Ahmed HM, Hussein MA, Alazonee AS. Radioprotective effect of hesperidin against gamma-irradiation-induced oxidative stress and biomechanical properties of bone in rats. Life Sci J 2013;10:2857-65.
49. Park S, Pradeep K, Ko KC. Protective effect of hesperidin against γ-radiation induced oxidative stress in Sprague-Dawley rats. Pharm Biol 2009;47:940-7.